MusthInsider

Latest On NewLink Genetics Corporation (NLNK):

Updated on: January 22, 2021

Date/Time	Type	Description	Signal
2020-11-26 20:58 EST	Financials	Company financials have been released.	Neutral
2020-11-08 00:20 EST	Financials	Company financials have been released.	Neutral
2020-11-07 16:37 EST	Financials	Company financials have been released.	Neutral
2020-09-26 13:32 EST	Financials	Company financials have been released.	Neutral
2020-09-17 05:38 EST	Financials	Company financials have been released.	Neutral
2020-08-14 09:36 EST	Financials	Company financials have been released.	Neutral
2020-08-06 13:21 EST	Financials	Company financials have been released.	Neutral
2020-07-31 01:49 EST	Financials	Company financials have been released.	Neutral
2020-07-30 05:17 EST	Financials	Company financials have been released.	Neutral
2020-07-27 13:14 EST	Financials	Company financials have been released.	Neutral
2020-07-23 17:53 EST	Financials	Company financials have been released.	Neutral
2020-07-09 09:29 EST	Financials	Company financials have been released.	Neutral
2020-07-01 17:16 EST	Financials	Company financials have been released.	Neutral
2020-06-26 09:28 EST	Financials	Company financials have been released.	Neutral
2020-06-14 05:12 EST	Financials	Company financials have been released.	Neutral
2020-06-12 05:34 EST	Financials	Company financials have been released.	Neutral
2020-05-27 05:40 EST	Financials	Company financials have been released.	Neutral
2020-05-06 05:46 EST	Financials	Company financials have been released.	Neutral
2020-05-01 05:17 EST	Financials	Company financials have been released.	Neutral
2020-04-25 19:38 EST	News	NewLink Genetics EPS beats by $0.06, beats on revenue	N/A
2020-04-25 19:30 EST	News	NewLink shareholders back Lumos merger	N/A
2020-04-07 18:24 EST	Insider Trade	CHAD ALLEN JOHNSON has directly acquired 709 shares and currently holds 709 shares.	Buy
2020-04-07 18:24 EST	Insider Trade	Emmett Cunningham has directly acquired 709 shares and currently holds 709 shares.	Buy
2020-04-07 18:24 EST	Insider Trade	KEVIN M. LALANDE has directly acquired 709 shares and currently holds 709 shares.	Buy
2020-04-07 18:24 EST	Insider Trade	Joseph S McCracken has directly acquired 709 shares and currently holds 709 shares.	Buy
2020-04-07 18:24 EST	Insider Trade	Thomas A. Raffin has directly acquired 709 shares and currently holds 7,889 shares.	Buy
2020-04-07 18:24 EST	Insider Trade	Lota S. Zoth has directly acquired 709 shares and currently holds 1,820 shares.	Buy
2020-04-03 21:15 EST	Financials	Company financials have been released.	Neutral
2020-04-03 18:26 EST	Insider Trade	Richard J Hawkins has directly acquired 25,000 shares and currently holds 744,575 shares.	Buy
2020-04-03 18:26 EST	Insider Trade	Eugene P. Kennedy has directly acquired 9,000 shares and currently holds 10,484 shares.	Buy
2020-04-03 18:26 EST	Insider Trade	Carl W. Langren has directly acquired 9,000 shares and currently holds 11,238 shares.	Buy
2020-04-03 18:26 EST	Insider Trade	Lori D Lawley has directly acquired 4,500 shares and currently holds 4,842 shares.	Buy
2020-04-03 18:26 EST	Insider Trade	John C. McKew has directly acquired 13,000 shares and currently holds 13,000 shares.	Buy
2020-04-03 18:26 EST	Insider Trade	BRADLEY J POWERS has directly acquired 4,500 shares and currently holds 4,555 shares.	Buy
2020-03-20 05:12 EST	Analyst Rating	The Analyst Target Price has increased from $4 to $36.	Buy
2020-03-20 05:12 EST	Stock Split	A stock split has occured on Mar 19, 2020 with a split factor of 1:9.	Neutral
2020-03-02 00:08 EST	Earnings Estimate	An EPS average of -$1.51 is estimated for the 2021 year.	Sell
2020-03-01 00:14 EST	Financials	Company financials have been released.	Neutral
2020-02-28 04:32 EST	Financials	Company financials have been released.	Neutral
2020-02-27 21:46 EST	Financials	Company financials have been released.	Neutral
2020-02-22 00:17 EST	Financials	Company financials have been released.	Neutral
2020-02-13 00:17 EST	Financials	Company financials have been released.	Neutral
2020-02-07 00:23 EST	Financials	Company financials have been released.	Neutral
2020-02-01 00:18 EST	Financials	Company financials have been released.	Neutral
2020-01-29 00:14 EST	Financials	Company financials have been released.	Neutral
2020-01-28 04:34 EST	Earnings	Earnings have been released on November 6, 2019, with -$0.39 earnings per share.	Sell
2020-01-28 00:20 EST	Financials	Company financials have been released.	Neutral
2020-01-25 00:08 EST	Financials	Company financials have been released.	Neutral
2020-01-16 00:22 EST	Financials	Company financials have been released.	Neutral
2020-01-06 20:10 EST	Insider Trade	Lota S. Zoth has directly acquired 2,100 shares and currently holds 10,006 shares.	Buy

About NewLink Genetics Corporation (NLNK):

NewLink Genetics Corporation, a late clinical-stage immuno-oncology company, focuses on discovering and developing novel immunotherapeutic products for the treatment of patients with cancer. It is developing Indoximod, an indoleamine-2, 3-dioxygenase (IDO) pathway inhibitor that is in clinical development in combination with other cancer therapeutics for patients with diffuse intrinsic pontine glioma, pediatric brain tumors, acute myeloid leukemia, and melanoma. The company also develops NLG207 in combination with paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer; NLG802, a prodrug of indoximod, which has completed Phase I clinical trial; and NLG919, a direct enzymatic inhibitor. The company has collaboration and license agreement with Genentech Inc. for the development and commercialization of NLG919, as well as a research collaboration for the discovery of next generation IDO/TDO inhibitors; and Merck Sharpe & Dohme Corp. to research, develop, and commercialize rVSV G-ZEBOV GP, an Ebola vaccine product candidate. NewLink Genetics Corporation was founded in 1999 and is headquartered in Ames, Iowa.

See Advanced Chart

General

Name NewLink Genetics Corporation
Symbol NLNK
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorOther
IndustryOther
Full Time Employees 21
Fiscal Year EndDecember
IPO Date2011-11-11
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryBiotechnology
Gic SubIndustryBiotechnology
Web URLwww.newlinkgenetics.com

Valuation

Price/Sales (Trailing 12 Mt.) 52.15
Price/Book (Most Recent Quarter) 1.24
Enterprise Value Revenue 8.94
Enterprise Value EBITDA 0.08

Financials

Most Recent Quarter 2019-12-31
Earnings Per Share -$1.02
Revenue Per Share $0
Gross Profit -18969000
Quarterly Earnings Growth 0%

Highlights

Market Capitalization 33.22 million
EBITDA -45165000
PEG Ratio -0.23
Analyst Target Price $36
Book Value Per Share $2.11

Share Statistics

% Held by Insiders <1%
Shares Short 2.31 million
Shares Short Prior Month 2.23 million

Technicals

50 Day Moving Average 8.18
200 Day Moving Average 2.75

Dividends

Dividend Date N/A
ExDividend Date N/A

NewLink Genetics Corporation (NLNK) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

NewLink Genetics Corporation (NLNK) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2019-12-31	2019-12-31	$433000	-$1.98	-$2.52	21.43%
2019-09-30	2019-09-30	$246000	-$3.51	-$2.43	-44.44%
2019-06-30	2019-06-30	$151000	-$2.43	-$2.61	6.9%
2019-03-31	2019-03-31	$106000	-$2.43	-$2.74	11.31%
2018-12-31	2019-02-28	$202000	-$0.28	-$0.34	16.5%
2018-09-30	2018-11-01	$120000	-$0.20	-$0.40	50.28%
2018-06-30	2018-08-01	$2.25 million	-$0.47	-$0.60	22.37%
2018-03-31	2018-05-04	$9.9 million	-$0.49	-$0.55	10.4%
2017-12-31	2018-03-02	$10.1 million	-$0.37	-$0.67	44.45%
2017-09-30	2017-11-02	$5.48 million	-$0.69	-$0.77	10.53%
2017-06-30	2017-07-28	$10.37 million	-$0.57	-$0.73	21.6%
2017-03-31	2017-05-04	$2.76 million	-$0.72	-$0.82	12.7%
2016-12-31	2017-02-28	$12.7 million	-$0.46	-$0.62	25.26%
2016-09-30	2016-11-01	$15.35 million	-$0.54	-$0.60	10.63%
2016-06-30	2016-07-29	$2.01 million	-$1.12	-$0.77	-45.58%
2016-03-31	2016-04-29	$5.31 million	-$0.82
2015-12-31	2016-02-29	$7.65 million	-$0.75
2015-09-30	2015-11-03	$14.21 million	-$0.55
2015-06-30	2015-07-31	$7.45 million	-$0.49
2015-03-31	2015-05-05	$39.2 million	$0.35
2014-12-31	2015-02-26	$169.25 million	$4.05
2014-09-30	2014-11-06	$2.8 million	-$0.20
2014-06-30	2014-08-05	$212000	-$0.33
2014-03-31	2014-05-06	$334000	-$0.33
2013-12-31	2014-03-12	$294000	-$0.31
2013-09-30	2013-11-12	$265000	-$0.32
2013-06-30	2013-08-07	$232000	-$0.28
2013-03-31	2013-05-06	$302000	-$0.33
2012-12-31	2013-02-28	$299000	-$0.30
2012-09-30	2012-10-31	$327000	-$0.28
2012-06-30	2012-08-14	$590000	-$0.31
2012-03-31	2012-05-11	$471000	-$0.23
2011-12-31	2012-03-29	$301000	-$0.27
2011-09-30	2011-11-30	$430000	-$0.19

NewLink Genetics Corporation (NLNK) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares

Cash Flow:

Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures

Balance Sheet:

Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

NewLink Genetics Corporation (NLNK) Chart:

NewLink Genetics Corporation (NLNK) News:

Below you will find a list of latest news for NewLink Genetics Corporation (NLNK) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

NewLink Genetics Corporation (NLNK) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent

NewLink Genetics Corporation (NLNK) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date	Form Type	Form Name	Link
2019-05-30	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1126234/000000000019009176/0000000000-19-009176-index.htm
2019-12-20	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1126234/000000000019016664/0000000000-19-016664-index.htm
2020-01-23	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1126234/000000000020000626/0000000000-20-000626-index.htm
2020-02-03	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1126234/000000000020001018/0000000000-20-001018-index.htm
2020-02-04	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1126234/000000000020001096/0000000000-20-001096-index.htm
2019-02-06	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1126234/000021545719004834/0000215457-19-004834-index.htm
2019-02-11	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1126234/000021545719007487/0000215457-19-007487-index.htm
2019-12-13	DFAN14A	Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1126234/000090266419004587/0000902664-19-004587-index.htm
2019-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1126234/000093041319000567/0000930413-19-000567-index.htm
2020-02-14	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1126234/000101359420000176/0001013594-20-000176-index.htm
2019-02-12	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1126234/000103738919000065/0001037389-19-000065-index.htm
2020-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1126234/000103738920000230/0001037389-20-000230-index.htm
2020-04-01	SC 13D	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1126234/000107261320000151/0001072613-20-000151-index.htm
2019-07-18	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1126234/000110465919040948/0001104659-19-040948-index.htm
2018-11-02	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1126234/000112623418000140/0001126234-18-000140-index.htm
2018-11-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623418000142/0001126234-18-000142-index.htm
2018-11-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623418000145/0001126234-18-000145-index.htm
2018-11-15	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623418000147/0001126234-18-000147-index.htm
2018-12-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623418000149/0001126234-18-000149-index.htm
2018-12-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623418000152/0001126234-18-000152-index.htm
2018-12-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623418000153/0001126234-18-000153-index.htm
2019-01-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000003/0001126234-19-000003-index.htm
2019-01-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000008/0001126234-19-000008-index.htm
2019-01-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000009/0001126234-19-000009-index.htm
2019-01-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000010/0001126234-19-000010-index.htm
2019-01-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000011/0001126234-19-000011-index.htm
2019-01-17	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000013/0001126234-19-000013-index.htm
2019-02-14	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000016/0001126234-19-000016-index.htm
2019-02-14	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000017/0001126234-19-000017-index.htm
2019-02-27	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000020/0001126234-19-000020-index.htm
2019-02-27	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000021/0001126234-19-000021-index.htm
2019-03-05	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000026/0001126234-19-000026-index.htm
2019-03-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000027/0001126234-19-000027-index.htm
2019-03-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000033/0001126234-19-000033-index.htm
2019-03-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000034/0001126234-19-000034-index.htm
2019-03-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000035/0001126234-19-000035-index.htm
2019-03-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000036/0001126234-19-000036-index.htm
2019-03-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000037/0001126234-19-000037-index.htm
2019-03-25	PRE 14A	Other preliminary proxy statements	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000040/0001126234-19-000040-index.htm
2019-04-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000042/0001126234-19-000042-index.htm
2019-04-05	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000045/0001126234-19-000045-index.htm
2019-05-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000049/0001126234-19-000049-index.htm
2019-05-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000051/0001126234-19-000051-index.htm
2019-05-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000057/0001126234-19-000057-index.htm
2019-05-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000058/0001126234-19-000058-index.htm
2019-05-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000059/0001126234-19-000059-index.htm
2019-05-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000060/0001126234-19-000060-index.htm
2019-05-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000061/0001126234-19-000061-index.htm
2019-05-15	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000063/0001126234-19-000063-index.htm
2019-05-23	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000065/0001126234-19-000065-index.htm
2019-06-20	SC TO-I	Tender offer statement by Issuer	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000071/0001126234-19-000071-index.htm
2019-06-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000073/0001126234-19-000073-index.htm
2019-07-01	S-3/A	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000077/0001126234-19-000077-index.htm
2019-07-22	SC TO-I/A	Tender offer statement by Issuer	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000082/0001126234-19-000082-index.htm
2019-07-30	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000084/0001126234-19-000084-index.htm
2019-08-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000086/0001126234-19-000086-index.htm
2019-08-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/0001126234-19-000099-index.htm
2019-08-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000100/0001126234-19-000100-index.htm
2019-08-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000101/0001126234-19-000101-index.htm
2019-08-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000102/0001126234-19-000102-index.htm
2019-08-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000103/0001126234-19-000103-index.htm
2019-08-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000104/0001126234-19-000104-index.htm
2019-08-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000105/0001126234-19-000105-index.htm
2019-08-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000106/0001126234-19-000106-index.htm
2019-08-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000107/0001126234-19-000107-index.htm
2019-08-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000108/0001126234-19-000108-index.htm
2019-08-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000109/0001126234-19-000109-index.htm
2019-08-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000110/0001126234-19-000110-index.htm
2019-08-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000112/0001126234-19-000112-index.htm
2019-08-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000115/0001126234-19-000115-index.htm
2019-08-12	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000118/0001126234-19-000118-index.htm
2019-08-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000120/0001126234-19-000120-index.htm
2019-08-29	SC TO-I/A	Tender offer statement by Issuer	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000122/0001126234-19-000122-index.htm
2019-09-17	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000124/0001126234-19-000124-index.htm
2019-09-30	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000130/0001126234-19-000130-index.htm
2019-09-30	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000131/0001126234-19-000131-index.htm
2019-10-01	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000133/0001126234-19-000133-index.htm
2019-11-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000136/0001126234-19-000136-index.htm
2019-11-06	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000137/0001126234-19-000137-index.htm
2019-11-06	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000142/0001126234-19-000142-index.htm
2019-11-06	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000144/0001126234-19-000144-index.htm
2019-11-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000148/0001126234-19-000148-index.htm
2019-11-12	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1126234/000112623419000152/0001126234-19-000152-index.htm
2020-01-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000005/0001126234-20-000005-index.htm
2020-01-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000006/0001126234-20-000006-index.htm
2020-01-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000007/0001126234-20-000007-index.htm
2020-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000009/0001126234-20-000009-index.htm
2020-02-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000013/0001126234-20-000013-index.htm
2020-02-28	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000014/0001126234-20-000014-index.htm
2020-03-03	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000018/0001126234-20-000018-index.htm
2020-03-27	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000022/0001126234-20-000022-index.htm
2020-03-30	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000030/0001126234-20-000030-index.htm
2020-03-30	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000031/0001126234-20-000031-index.htm
2020-03-30	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000032/0001126234-20-000032-index.htm
2020-03-30	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000033/0001126234-20-000033-index.htm
2020-03-30	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000035/0001126234-20-000035-index.htm
2020-04-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000037/0001126234-20-000037-index.htm
2020-04-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000044/0001126234-20-000044-index.htm
2020-04-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000045/0001126234-20-000045-index.htm
2020-04-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000046/0001126234-20-000046-index.htm
2020-04-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000047/0001126234-20-000047-index.htm
2020-04-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000048/0001126234-20-000048-index.htm
2020-04-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000049/0001126234-20-000049-index.htm
2020-04-07	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000058/0001126234-20-000058-index.htm
2020-04-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000059/0001126234-20-000059-index.htm
2020-04-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000060/0001126234-20-000060-index.htm
2020-04-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000061/0001126234-20-000061-index.htm
2020-04-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000062/0001126234-20-000062-index.htm
2020-04-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000063/0001126234-20-000063-index.htm
2020-04-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000064/0001126234-20-000064-index.htm
2020-04-24	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000067/0001126234-20-000067-index.htm
2020-04-29	10-K/A	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000070/0001126234-20-000070-index.htm
2020-05-14	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000072/0001126234-20-000072-index.htm
2020-05-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000074/0001126234-20-000074-index.htm
2020-06-02	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000076/0001126234-20-000076-index.htm
2019-11-20	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000114036119020976/0001140361-19-020976-index.htm
2019-11-20	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1126234/000114036119020977/0001140361-19-020977-index.htm
2019-11-20	8-K/A	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000114036119020980/0001140361-19-020980-index.htm
2019-11-20	PREM14A	Preliminary proxy statements relating to merger or acquisition	https://www.sec.gov/Archives/edgar/data/1126234/000114036119020983/0001140361-19-020983-index.htm
2019-12-16	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1126234/000114036119022561/0001140361-19-022561-index.htm
2019-12-20	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000114036119022996/0001140361-19-022996-index.htm
2019-12-20	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1126234/000114036119022997/0001140361-19-022997-index.htm
2020-01-09	PRER14A	Preliminary Proxy Soliciting materials	https://www.sec.gov/Archives/edgar/data/1126234/000114036120000548/0001140361-20-000548-index.htm
2020-01-09	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1126234/000114036120000550/0001140361-20-000550-index.htm
2020-01-29	PRER14A	Preliminary Proxy Soliciting materials	https://www.sec.gov/Archives/edgar/data/1126234/000114036120001626/0001140361-20-001626-index.htm
2020-01-28	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1126234/000114036120001627/0001140361-20-001627-index.htm
2020-02-04	PRER14A	Preliminary Proxy Soliciting materials	https://www.sec.gov/Archives/edgar/data/1126234/000114036120002171/0001140361-20-002171-index.htm
2020-02-04	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1126234/000114036120002172/0001140361-20-002172-index.htm
2020-02-10	DEFM14A	Definitive proxy statement relating to merger or acquisition	https://www.sec.gov/Archives/edgar/data/1126234/000114036120002644/0001140361-20-002644-index.htm
2020-02-13	DEFR14A	Revised definitive proxy soliciting materials	https://www.sec.gov/Archives/edgar/data/1126234/000114036120003160/0001140361-20-003160-index.htm
2020-03-06	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1126234/000114036120005019/0001140361-20-005019-index.htm
2020-03-18	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000114036120006205/0001140361-20-006205-index.htm
2020-06-01	8-K/A	Current report	https://www.sec.gov/Archives/edgar/data/1126234/000114036120012764/0001140361-20-012764-index.htm
2019-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1126234/000114420419008084/0001144204-19-008084-index.htm
2020-03-30	SC 13D	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1126234/000119312520091134/0001193125-20-091134-index.htm
2020-03-20	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1126234/000119380520000380/0001193805-20-000380-index.htm
2019-03-18	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1126234/000121465919002152/0001214659-19-002152-index.htm
2019-02-11	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1126234/000132544719000011/0001325447-19-000011-index.htm
2019-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1126234/000151211319000002/0001512113-19-000002-index.htm
2020-02-18	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1126234/000151211320000002/0001512113-20-000002-index.htm
2019-07-22	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1126234/999999999519001657/9999999995-19-001657-index.htm
2018-12-17	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1126234/999999999718009561/9999999997-18-009561-index.htm
2019-03-19	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1126234/999999999719001409/9999999997-19-001409-index.htm

NewLink Genetics Corporation (NLNK) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of NewLink Genetics Corporation (NLNK). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: < 1%
Institutional Ownership: < 1%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2020-01-02	Lota S. Zoth	Director	Buy	2,100.00			10,006.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000007/0001126234-20-000007-index.htm
2020-04-01	Eugene P. Kennedy	Chief Medical Officer	Buy	9,000.00			10,484.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000045/0001126234-20-000045-index.htm
2020-04-01	Carl W. Langren	Chief Financial Officer	Buy	9,000.00			11,238.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000046/0001126234-20-000046-index.htm
2020-04-01	John C. McKew	Chief Scientific Officer	Buy	13,000.00			13,000.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000048/0001126234-20-000048-index.htm
2020-04-03	Lota S. Zoth	Director	Buy	709.00			1,820.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000064/0001126234-20-000064-index.htm
2018-12-12	Carl W. Langren	Chief Financial Officer	Buy	2,564.00	0.80	2,051.20	21,469.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623418000152/0001126234-18-000152-index.htm
2018-12-12	Charles J. Jr. Link	Chairman of the Board and CEO	Buy	2,564.00	0.80	2,051.20	262,406.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623418000153/0001126234-18-000153-index.htm
2020-04-01	BRADLEY J POWERS	General Counsel	Buy	4,500.00			4,555.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000049/0001126234-20-000049-index.htm
2020-04-01	Lori D Lawley	Principal Accounting Officer	Buy	4,500.00			4,842.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000047/0001126234-20-000047-index.htm
2020-04-03	CHAD ALLEN JOHNSON	Director	Buy	709.00			709.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000059/0001126234-20-000059-index.htm
2020-04-03	Emmett Cunningham	Director	Buy	709.00			709.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000060/0001126234-20-000060-index.htm
2020-04-03	Joseph S McCracken	Director	Buy	709.00			709.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000062/0001126234-20-000062-index.htm
2020-04-03	KEVIN M. LALANDE	Director	Buy	709.00			709.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000061/0001126234-20-000061-index.htm
2020-04-01	Richard J Hawkins	Chief Executive Officer	Buy	25,000.00			744,575.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000044/0001126234-20-000044-index.htm
2020-04-03	Thomas A. Raffin	Director	Buy	709.00			7,889.00	https://www.sec.gov/Archives/edgar/data/1126234/000112623420000063/0001126234-20-000063-index.htm

NewLink Genetics Corporation

(NASDAQ:NLNK)